Protocol Complexity And Patient Enrollment Intensify Challenges In Oncology Trials

In May 2021, Tufts Center for the Study of Drug Development published their latest IMPACT report on oncology research. The research shows oncology trials are 30%-40% longer, have more substantial protocol amendments, and have more internal reviews compared to other trials. The six headline conclusions have implications for your technology that warrant exploration, because technology choices shape our approach to supporting clinical trials. Learn strategies to better handle these challenges.